发明人马晓峰,徐明华,张德明. "Method for the Synthesis of {[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}(methyl)amine dihydrochloride" [P]. 中国发明专利, 专利号 CN 108959845 A, 授权公告日 2024-12-06.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of {[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}(methyl)amine dihydrochloride in Pharmaceutical Formulations". Food Chem., 2016, 1592, (5), 3861-3890.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of {[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}(methyl)amine dihydrochloride as an Impurity". Molecules, 2017, 1888, 4042-4060.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of {[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}(methyl)amine dihydrochloride Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1260, (10), 5435-5461.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate {[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}(methyl)amine dihydrochloride Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2020, 1176, (4), 6701-6723.